Cargando…
Using Pharmacokinetic Modeling and Electronic Health Record Data to Predict Clinical and Safety Outcomes after Methylprednisolone Exposure during Cardiopulmonary Bypass in Neonates
BACKGROUND: Infants undergoing cardiac surgery with cardiopulmonary bypass (CPB) frequently receive intraoperative methylprednisolone (MP) to suppress CPB-related inflammation; however, the optimal dosing strategy and efficacy of MP remain unclear. METHODS: We retrospectively analyzed all infants un...
Autores principales: | Foote, Henry P., Wu, Huali, Balevic, Stephen J., Thompson, Elizabeth J., Hill, Kevin D., Graham, Eric M., Hornik, Christoph P., Kumar, Karan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361697/ https://www.ncbi.nlm.nih.gov/pubmed/37484782 http://dx.doi.org/10.32604/chd.2023.026262 |
Ejemplares similares
-
Population Pharmacokinetic/Pharmacodynamic Modeling of Methylprednisolone in Neonates Undergoing Cardiopulmonary Bypass
por: Hornik, Christoph P., et al.
Publicado: (2019) -
A point-of-care pharmacokinetic/pharmacodynamic trial in critically ill children: Study design and feasibility
por: Thompson, Elizabeth J., et al.
Publicado: (2023) -
A comparison of three dose timings of methylprednisolone in infant cardiopulmonary bypass
por: Withington, Davinia E, et al.
Publicado: (2014) -
Methylprednisolone Plasma Concentrations During Cardiac Surgery With Cardiopulmonary Bypass in Pediatric Patients
por: van Saet, Annewil, et al.
Publicado: (2021) -
Effects of high-dose methylprednisolone on neonatal pulmonary function after cardiopulmonary bypass and deep hypothermic circulatory arrest
por: Abdul-Khaliq, H, et al.
Publicado: (2001)